What's on the agenda this month
by Emily Zerling, Health Policy Executive
The month of December for the pharma and health sector will open on a vote from the INTA Committee on its draft opinion on the proposal on supplementary protection certificate for medicinal products on 3 December.
The 7th annual regulatory conference organised by the European Biopharmaceutical Enterprises will take place on 4 December. This conference will explore how fostering collaboration between regulators, HTA bodies, payers and other stakeholders can help ATMP developers meet evidence requirements for better patient access.
Furthermore, on 6 December, the European Commission is organising the Health Equity Pilot Project: Final Conference. This event will focus on understanding health inequalities and behaviours, inequalities in alcohol consumption and harm, and inequalities in overweight and obesity. The European Commission will also be organising a conference focusing on "Enhancing Healthcare Cooperation in Cross-border Regions" on 4 December 2018.
Look ahead to 2019 with our Commission Work Programme 2019 briefing.
Support your strategic planning with DeHavilland EU
DeHavilland EU can help with your forward planning, by giving you early warning of the key events impacting your sector.
Contact us for a free consultation today to find out how we can help you manage risks and identify opportunities.
Emily monitors the latest EU developments on health, agriculture, fisheries, animal welfare and international development. She was previously a trainee at the Luxembourg Representation to the EU in Brussels and graduated with a Master’s degree in European Affairs.